Items where authors include "Mall, M.A."

Article

Uluer, A.Z., MacGregor, G., Azevedo, P. et al. (103 more authors) (2023) Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6). pp. 550-562. ISSN 2213-2600

Sutharsan, S., McKone, E.F., Downey, D.G. et al. (51 more authors) (2022) Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. The Lancet Respiratory Medicine, 10 (3). pp. 267-277. ISSN 2213-2600

Bingle, L. orcid.org/0000-0002-4587-9384, Wilson, K., Musa, M. et al. (8 more authors) (2012) BPIFB1 (LPLUNC1) is upregulated in cystic fibrosis lung disease. Histochemistry and Cell Biology, 138 (5). pp. 749-758. ISSN 0948-6143